Medium materiality6/10
Jazz Pharmaceuticals price target lowered to $296 from $299 at RBC Capital
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital lowers Jazz Pharmaceuticals target to $296 from $299; current price $219.06.
- Target $296 (from $299); price $219.06; RBC Capital
Key facts
- 01
Target: $296
- 02
Posted price: $219.06
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.